IBRDC2, identified as ring finger protein 144B (RNF144B), plays a pivotal role in cellular processes by its involvement in the ubiquitin-proteasome pathway, which is crucial for protein degradation and turnover. This protein contains both a RING (Really Interesting New Gene) finger domain, which is essential for its ubiquitin ligase activity, and an IBR (In-Between-RING) domain, characteristic of a subclass of RING finger proteins. The expression of IBRDC2 is widespread, with pronounced levels in thyroid and lung tissues, suggesting its significance in the cellular metabolism of diverse organs. Its gene resides within a complex network of signaling pathways, ensuring tight regulation of apoptosis and proteostasis, thereby maintaining cellular homeostasis. Given its mitochondrial localization, IBRDC2 may have specific functions in mitochondrial quality control and dynamics, which are crucial for energy production and metabolic regulation.
The upregulation of IBRDC2 expression could potentially be stimulated by a variety of chemical compounds, each acting through distinct biochemical pathways. Compounds like retinoic acid, which acts through nuclear receptors, might initiate transcriptional activation of genes, including IBRDC2, by binding to retinoic acid response elements in the gene promoter. Similarly, forskolin could induce the expression of IBRDC2 via the cAMP signaling pathway, leading to the activation of protein kinase A (PKA) and subsequent phosphorylation of transcription factors that enhance gene transcription. Histone deacetylase inhibitors, such as Trichostatin A and Sodium Butyrate, may increase IBRDC2 expression by remodeling chromatin to a more open state, facilitating the binding of transcription machinery. DNA methylation inhibitors like 5-Azacytidine could stimulate demethylation of the IBRDC2 gene promoter, thereby promoting gene transcription. Agents such as Beta-Estradiol might work through hormone receptor-mediated pathways to induce the expression of IBRDC2 by interacting with specific hormone response elements. The activation of transcription factors such as NF-kB by Curcumin could also lead to increased transcription of IBRDC2. Each of these compounds represents a potential activator of IBRDC2 expression, acting through unique mechanisms to upregulate this essential protein.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid may upregulate IBRDC2 by binding to its nuclear receptors, which could initiate transcriptional activation of genes including IBRDC2. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin could stimulate cAMP production, which may trigger a cascade leading to the transcriptional activation of cAMP response element-associated genes like IBRDC2. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may upregulate IBRDC2 by inhibiting histone deacetylases, resulting in a more accessible chromatin structure for IBRDC2 gene transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferases, 5-Azacytidine could potentially stimulate demethylation of the IBRDC2 gene promoter, leading to its increased expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone could stimulate IBRDC2 expression by activating glucocorticoid receptors that bind to glucocorticoid response elements in the IBRDC2 gene promoter. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Thalidomide might upregulate IBRDC2 by altering the transcription of growth factors, thereby indirectly initiating upregulation of IBRDC2. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate may stimulate an increase in IBRDC2 transcription by causing hyperacetylation of histones associated with the IBRDC2 gene. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD 98059 could theoretically promote IBRDC2 expression by inhibiting MEK, which might lead to the activation of transcription factors specific to IBRDC2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY 294002, by inhibiting PI3K, could upregulate IBRDC2 expression by attenuating downstream inhibition of transcription factors that target the IBRDC2 gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin might induce IBRDC2 expression by inhibiting mTOR, a key negative regulator of cellular growth and proliferation, thereby promoting IBRDC2 transcription. | ||||||